Testicular cancer differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 61: Line 61:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Embryonal carcinoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Embryonal carcinoma
| style="background: #F5F5F5; padding: 5px;" |Malignant
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Usually located in parenchyma of testis
* May be nonpalpable
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Hemorrhagic mass with necrosis
* Worse prognosis than seminoma
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Rare type
* Peak incidence at the age of 30 years old
* Usually mixed with other types
| style="background: #F5F5F5; padding: 5px;" |Early metastasis to:
* retroperitoneum
* Lung
* Liver
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:
* CD30
* HCG
May stain positively for :
* AFP, when mixed with other tumors
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Primitive epithelial cells with marked pleomorphism
* Often mixed histopathological features (solid, papillary, tubular, pseudoglandular)
| style="background: #F5F5F5; padding: 5px;" |+
| style="background: #F5F5F5; padding: 5px;" |±
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Unremarkable
* May present with abdominal/ pelvic mass
* Abdominal pain may be present
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Elevated serum hCG
| style="background: #F5F5F5; padding: 5px;" |
* Elevated serum AFP, when mixed with other tumor types
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Ultrasound:
| style="background: #F5F5F5; padding: 5px;" |
* Usually hypoechoic mass
| style="background: #F5F5F5; padding: 5px;" |
* Invasion to tunica albuginea
| style="background: #F5F5F5; padding: 5px;" |
* Irregular calcifications
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Yolk sac tumor
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Yolk sac tumor

Revision as of 17:06, 23 January 2019

Testicular cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Testicular cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Testicular cancer differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Testicular cancer differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Testicular cancer differential diagnosis

CDC on Testicular cancer differential diagnosis

Testicular cancer differential diagnosis in the news

Blogs on Testicular cancer differential diagnosis

Directions to Hospitals Treating Testicular cancer

Risk calculators and risk factors for Testicular cancer differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Testicular cancer must be differentiated from epididymitis, hematocele, hydrocele, spermatocele, granulomatous orchitis, and varicocele.

Differentiating Testicular cancer from other Diseases

Testicular cancer must be differentiated from:

Diseases Benign/ Malignant Unilateral/Bilateral History Demography Metastasis Genetics Histopathology Clinical manifestations Para-clinical findings
Pain Mass Physical examination
Lab Findings Imaging
Germ Cell Seminoma[1][2] Malignant Unilateral
  • History of cryptorchidism
  • Excellent prognosis
  • Most common among age of 15-35 years old
  • Does not occur during infancy
  • Late metastasis
Stains positively for:
  • ALP
  • C-KIT
  • CD30
  • EMA
  • Glycogen
  • Large cells wit watery cytoplasm
  • Fried egg appearance
- +
  • Palpable, nontender unilateral testicular mass
  • Usually homogeneous enlargement
  • Elevated serum placental ALP (PALP)
Ultrasound:
  • Homogeneous hypoechoic intratesticular mass
  • Cysts and calcificications are uncommon
  • Inhomogenous feature in larger mass
Embryonal carcinoma Malignant
  • Usually located in parenchyma of testis
  • May be nonpalpable
  • Hemorrhagic mass with necrosis
  • Worse prognosis than seminoma
  • Rare type
  • Peak incidence at the age of 30 years old
  • Usually mixed with other types
Early metastasis to:
  • retroperitoneum
  • Lung
  • Liver
Stains positively for:
  • CD30
  • HCG

May stain positively for :

  • AFP, when mixed with other tumors
  • Primitive epithelial cells with marked pleomorphism
  • Often mixed histopathological features (solid, papillary, tubular, pseudoglandular)
+ ±
  • Unremarkable
  • May present with abdominal/ pelvic mass
  • Abdominal pain may be present
  • Elevated serum hCG
  • Elevated serum AFP, when mixed with other tumor types
Ultrasound:
  • Usually hypoechoic mass
  • Invasion to tunica albuginea
  • Irregular calcifications
Yolk sac tumor
Teratoma
Choriocarcinoma
Diseases Benign/ Malignant Unilateral/Bilateral History Demography Metastasis Genetics Histopathology Pain Mass Physical exam Lab Findings Imaging
Non germ cell Leydig cell tumor
Sertoli cell tumor
Testicular lymphoma
Carcinoma in situ of the testicle

References

  1. Siegel RL, Miller KD, Jemal A (2016). "Cancer statistics, 2016". CA Cancer J Clin. 66 (1): 7–30. doi:10.3322/caac.21332. PMID 26742998.
  2. Miller FH, Whitney WS, Fitzgerald SW, Miller EI (1999). "Seminomas complicating undescended intraabdominal testes in patients with prior negative findings from surgical exploration". AJR Am J Roentgenol. 172 (2): 425–8. doi:10.2214/ajr.172.2.9930796. PMID 9930796.


Template:WikiDoc Sources